Table 3.
Differences in physiological and biochemical indicators between the control group and treatment group before and after rehabilitation treatment.
| Variables | All patients (n = 80) | Control group (n = 40) | Treatment group (n = 40) | p-value |
|---|---|---|---|---|
| NSE, Neuron-Specific Enolase (ng/mL) | ||||
| Before rehabilitation treatment | 20.38 (13.51–26.76) | 20.37 (13.79–26.13) | 20.46 (13.51–26.76) | 0.43 |
| After rehabilitation treatment | 12.70 (8.37–17.26) | 13.93 (10.35–17.26) | 11.49 (8.37–16.63) | 0.000757 |
| NFL, Neurofilament light (pg/mL) | ||||
| Before rehabilitation treatment | 150.00 (110.31–195.19) | 155.91 (110.31–194.49) | 145.51 (120.36–195.19) | 0.637 |
| After rehabilitation treatment | 66.86 (52.99–81.45) | 71.83 (57.66–81.45) | 61.95 (52.99–78.91) | 9.73E-05 |
| BDNF, Brain-Derived Neurotrophic Factor | ||||
| Before rehabilitation treatment | 7.49 (4.51–10.79) | 7.49 (4.55–10.74) | 7.39 (4.51–10.79) | 0.977 |
| After rehabilitation treatment | 18.95 (9.49–31.66) | 14.69 (9.49–29.42) | 24.57 (10.09–31.66) | 0.00378 |
| SpO2, Oxygen Saturation (%) | ||||
| Before rehabilitation treatment | 93.05 (91.12–95.35) | 92.80 (91.23–95.34) | 93.20 (91.12–95.35) | 0.686 |
| After rehabilitation treatment | 97.10 (95.24–98.79) | 96.81 (95.24–98.79) | 97.64 (95.28–98.75) | 0.0304 |
| Red Cell Distribution Width, RDW (%) | ||||
| Before rehabilitation treatment | 18.23 (15.74–20.00) | 18.04 (16.04–19.92) | 18.46 (15.74–20.00) | 0.57 |
| After rehabilitation treatment | 12.96 (11.28–15.25) | 13.70 (11.29–15.23) | 12.66 (11.28–15.25) | 0.0166 |
| Platelet Count, PLT (× 109/L) | ||||
| Before rehabilitation treatment | 441.49 (353.29–513.52) | 446.26 (353.29–513.52) | 434.27 (353.76–512.95) | 0.744 |
| After rehabilitation treatment | 280.19 (181.43–409.24) | 312.49 (208.65–409.24) | 253.44 (181.43–404.41) | 0.00244 |
| CRP, C-Reactive Protein (mg/L) | ||||
| Before rehabilitation treatment | 26.01 (18.55–35.96) | 26.86 (19.19–35.54) | 25.16 (18.55–35.96) | 0.465 |
| After rehabilitation treatment | 7.82 (4.33–12.31) | 9.45 (4.33–12.31) | 7.12 (4.44–11.37) | 0.000286 |
| IL-10, Interleukin-10 (pg/mL) | ||||
| Before rehabilitation treatment | 23.65 (13.52–31.90) | 22.70 (14.06–31.90) | 25.29 (13.52–31.90) | 0.482 |
| After rehabilitation treatment | 7.03 (3.62–9.58) | 6.54 (3.62–9.53) | 7.94 (4.12–9.58) | 0.00453 |
| IL-6, Interleukin-6 (pg/mL) | ||||
| Before rehabilitation treatment | 20.29 (13.21–28.60) | 20.50 (13.21–28.60) | 20.23 (13.31–28.29) | 0.817 |
| After rehabilitation treatment | 5.63 (3.20–8.58) | 6.63 (3.20–8.58) | 4.91 (3.21–8.19) | 0.0026 |